Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.16T | 1.67T | 1.60T | 1.70T | 1.76T |
Gross Profit | 710.17B | 954.34B | 885.44B | 946.04B | 970.47B |
EBITDA | 387.69B | 698.75B | 515.41B | 603.29B | 651.43B |
Net Income | 278.81B | 490.60B | 432.77B | 477.69B | 480.38B |
Balance Sheet | |||||
Total Assets | 3.40T | 3.15T | 2.85T | 2.66T | 2.45T |
Cash, Cash Equivalents and Short-Term Investments | 2.06T | 2.25T | 1.88T | 1.71T | 1.74T |
Total Debt | 0.00 | 6.13B | 6.29B | 6.23B | 5.77B |
Total Liabilities | 673.07B | 546.40B | 587.82B | 593.08B | 572.30B |
Stockholders Equity | 2.72T | 2.60T | 2.27T | 2.07T | 1.87T |
Cash Flow | |||||
Free Cash Flow | -6.94B | 445.97B | 300.65B | 282.07B | 605.10B |
Operating Cash Flow | 12.07B | 462.10B | 322.84B | 289.66B | 612.11B |
Investing Cash Flow | 753.06B | -630.63B | 111.51B | 93.70B | -136.53B |
Financing Cash Flow | -195.13B | -236.96B | -290.97B | -337.01B | -194.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $81.37B | 18.81 | 23.93% | 2.05% | 1.26% | 6.84% | |
76 Outperform | $112.70B | 56.45 | 11.31% | 1.08% | 2.17% | -25.07% | |
76 Outperform | $44.51B | 44.67 | 15.46% | 0.43% | 2.68% | -6.15% | |
72 Outperform | $89.80B | ― | -401.21% | ― | 27.39% | 16.59% | |
69 Neutral | $9.18B | ― | -4.29% | ― | 21.11% | 87.93% | |
60 Neutral | $43.99B | 4.24 | -10.43% | 4.00% | 2.31% | -34.39% | |
55 Neutral | $42.90B | ― | -89.29% | ― | 7.33% | -7.46% |